News
Posted: March 15, 2010 | News, Press
Amsino ‘s IV Administration Set Cleared by FDA
Shanghai, March 15, 2010 – Amsino Medical Group has recently received a new 510 (k) approval (K093773) by US FDA, clearing Amsino’s IV Administration Sets including AMSafe 3 IV Sets for marketing and commercial distribution in the United States.
“This approval allows Amsino to offer a complete IV Administration product portfolio so that we can better service our customers in the U.S.”, said Gang Chen, Vice President of Quality Assurance and Regulatory Affairs of Amsino Medical Group.
Posted: January 4, 2010 | News, Press
Chester Chai Promoted Vice President of Finance
Shanghai, Jan 04, 2010 — Amsino Medical Group is pleased to announce that Mr. Chester Chai is promoted as Vice President of Finance at Amsino Medical Group Company Limited.
Chester received his BS in Mechanical Engineering from Shanghai Jiao Tong University, MS in Accounting from University of Colorado at Boulder, and MBA from Kellogg School of Management, Northwestern University. Chester is also a CPA (Certified Public Accountant).
Posted: May 21, 2009 | News, Press
Amsino Receives SFDA Clearance for Amsino IV Administration Set
Amsino Medical Group has recently received the registration certificate (SFDA 3660303 2009) for Amsino IV Administration Sets issued by State Food and Drug Administration. The certificate will enable Amsino to manufacture and distribute Amsino IV Administration Sets in China.